| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| SHR-9146 | HTI-1090; SHR-9146 | Phase 1 Clinical | Jiangsu Hengrui Medicine Co Ltd | Solid tumours; Neoplasms | Details |
| LPM-3480226 | LY-01013; LPM-3480226 | Phase 1 Clinical | Luye Pharma Group Ltd | Solid tumours | Details |
| TQB-3562 | TQB-3562 | Phase 1 Clinical | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Lianyungang Runzhong Pharmaceutical Co Ltd | Solid tumours | Details |